{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:06:38Z","timestamp":1794665198012,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e28256","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T13:01:03Z","timestamp":1710507663000},"page":"e28256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Biomimetic nanocarriers loaded with temozolomide by cloaking brain-targeting peptides for targeting drug delivery system to promote anticancer effects in glioblastoma cells"],"prefix":"10.1016","volume":"10","author":[{"given":"Huaming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e28256_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: State of the art and future directions, CA","volume":"70","author":"Tan","year":"2020","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.heliyon.2024.e28256_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","article-title":"Challenges in glioblastoma research: focus on the tumor microenvironment","volume":"9","author":"Bikfalvi","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.heliyon.2024.e28256_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120758","article-title":"Highlights in targeted nanoparticles as a delivery strategy for glioma treatment","volume":"604","author":"Luiz","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2024.e28256_bib4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1080\/17425247.2020.1810015","article-title":"Nanoparticle-mediated therapeutic compounds delivery to glioblastoma","volume":"17","author":"Gallego","year":"2020","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.heliyon.2024.e28256_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cancers12010242","article-title":"Nano-therapies for glioblastoma treatment","volume":"12","author":"Alphand\u00e9ry","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e28256_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-01928-9","article-title":"Enhancement of therapies for glioblastoma (GBM) using nanoparticle-based delivery systems","volume":"22","author":"Wiwatchaitawee","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.heliyon.2024.e28256_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/cancers13020195","article-title":"Nanotechnology and nanocarrier-based drug delivery as the potential therapeutic strategy for glioblastoma multiforme: an update","volume":"13","author":"Hsu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e28256_bib8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/pharmaceutics12090860","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as smart drug delivery systems in the treatment of glioblastoma multiforme","volume":"12","author":"Jnaidi","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2024.e28256_bib9","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3390\/pharmaceutics15071820","article-title":"Recent advances in zein-based nanocarriers for precise cancer therapy","volume":"15","author":"Huang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2024.e28256_bib10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s13346-020-00738-z","article-title":"Zein nanoparticles as low-cost, safe, and effective carriers to improve the oral bioavailability of resveratrol","volume":"10","author":"Nunes","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.heliyon.2024.e28256_bib11","article-title":"Zein-based micro-and nano-constructs and biologically therapeutic cues with multi-functionalities for oral drug delivery systems","volume":"58","author":"Raza","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.heliyon.2024.e28256_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10717544.2019.1704942","article-title":"Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer","volume":"27","author":"Yu","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.heliyon.2024.e28256_bib13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jphp.13223","article-title":"Preparation, characterization and preliminary pharmacokinetic study of pH-sensitive Hydroxyapatite\/Zein nano-drug delivery system for doxorubicin hydrochloride","volume":"72","author":"Zha","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28256_bib14","doi-asserted-by":"crossref","first-page":"21707","DOI":"10.1021\/acsanm.3c03923","article-title":"Zein nanoparticles for controlled intestinal drug release for the treatment of gastrointestinal infections","volume":"6","author":"Pena-Bahamonde","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.heliyon.2024.e28256_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170542","article-title":"Applications of amphipathic and cationic cyclic cell-penetrating peptides: significant therapeutic delivery tool","volume":"141","author":"Sajid","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.heliyon.2024.e28256_bib16","doi-asserted-by":"crossref","first-page":"e3354","DOI":"10.1002\/psc.3354","article-title":"Design of acid\u2010activated cell\u2010penetrating peptides with nuclear localization capacity for anticancer drug delivery","volume":"27","author":"Huang","year":"2021","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.heliyon.2024.e28256_bib17","article-title":"Polymeric micelles functionalized with cell penetrating peptides as potential pH-sensitive platforms in drug delivery for cancer therapy: a review, Arab","volume":"14","author":"Khan","year":"2021","journal-title":"J. Chem."},{"key":"10.1016\/j.heliyon.2024.e28256_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1021\/acs.molpharmaceut.2c00629","article-title":"The recent advance of cell-penetrating and tumor-targeting peptides as drug delivery systems based on tumor microenvironment","volume":"20","author":"Zhang","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.heliyon.2024.e28256_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10717544.2019.1706669","article-title":"SPA: a peptide antagonist that acts as a cell-penetrating peptide for drug delivery","volume":"27","author":"Song","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.heliyon.2024.e28256_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/17425247.2022.2034784","article-title":"An update on cell-penetrating peptides with intracellular organelle targeting","volume":"19","author":"Cerrato","year":"2022","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.heliyon.2024.e28256_bib21","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/pharmaceutics13091391","article-title":"Delivery of various cargos into cancer cells and tissues via cell-penetrating peptides: a review of the last decade","volume":"13","author":"Shoari","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2024.e28256_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/psc.3300","article-title":"New generation of cell\u2010penetrating peptides: functionality and potential clinical application","volume":"27","author":"Reissmann","year":"2021","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.heliyon.2024.e28256_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/17425247.2020.1739646","article-title":"Advances in the use of cell penetrating peptides for respiratory drug delivery","volume":"17","author":"Gomes dos Reis","year":"2020","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.heliyon.2024.e28256_bib24","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.3390\/ijms24065851","article-title":"RVG peptide-functionalized favipiravir nanoparticle delivery system facilitates antiviral therapy of neurotropic virus infection in a mouse model","volume":"24","author":"Ren","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e28256_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10395","article-title":"Targeted brain delivery of RVG29\u2010modified rifampicin\u2010loaded nanoparticles for Alzheimer's disease treatment and diagnosis","volume":"7","author":"Zhou","year":"2022","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e28256_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112615","article-title":"Enhanced activity of AZD5582 and SM-164 in rabies virus glycoprotein-lactoferrin-liposomes to downregulate inhibitors of apoptosis proteins in glioblastoma","volume":"133","author":"Kuo","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.heliyon.2024.e28256_bib27","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1039\/D1RA00550B","article-title":"Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system","volume":"11","author":"Wang","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.heliyon.2024.e28256_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2023.03.003","article-title":"Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma","author":"Ji","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.heliyon.2024.e28256_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/pharmaceutics12020093","article-title":"Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-modified PLGA nanoparticles","volume":"12","author":"Chung","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2024.e28256_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112505","article-title":"Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment","volume":"215","author":"Wang","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.heliyon.2024.e28256_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-4939-9798-5_15","article-title":"Lipid nanocarriers for enhanced delivery of temozolomide to the brain","author":"Khosa","year":"2020","journal-title":"Drug Deliv. Syst."},{"key":"10.1016\/j.heliyon.2024.e28256_bib32","article-title":"Hyaluronic acid conjugated albumin nanoparticles for efficient receptor mediated brain targeted delivery of temozolomide","volume":"61","author":"Kudarha","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.heliyon.2024.e28256_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2021.08.011","article-title":"Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers","volume":"168","author":"Di Filippo","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.heliyon.2024.e28256_bib34","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3390\/pharmaceutics13081270","article-title":"Targeted delivery of liposomal temozolomide enhanced anti-glioblastoma efficacy through ultrasound-mediated blood\u2013brain barrier opening","volume":"13","author":"Song","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2024.e28256_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jconrel.2021.07.003","article-title":"Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy","volume":"336","author":"Yasaswi","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2024.e28256_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jconrel.2021.09.005","article-title":"Charge-reversal biodegradable MSNs for tumor synergetic chemo\/photothermal and visualized therapy","volume":"338","author":"Li","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2024.e28256_bib37","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1039\/C6TB01528J","article-title":"Tailored smart bioactive glass nanoassembly for dual antibiotic in vitro sustained release against osteomyelitis","volume":"4","author":"Gupta","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.heliyon.2024.e28256_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017762118","article-title":"Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR\/ERK pathway","volume":"118","author":"Zheng","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2024.e28256_bib39","doi-asserted-by":"crossref","first-page":"11765","DOI":"10.1021\/acs.langmuir.0c01443","article-title":"Protein-coated aryl modified gold nanoparticles for cellular uptake study by osteosarcoma cancer cells","volume":"36","author":"Hameed","year":"2020","journal-title":"Langmuir"},{"key":"10.1016\/j.heliyon.2024.e28256_bib40","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/10717544.2019.1582730","article-title":"Improving cellular uptake of therapeutic entities through interaction with components of cell membrane","volume":"26","author":"Zhang","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.heliyon.2024.e28256_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2017.10.026","article-title":"Increased cellular uptake of peptide-modified PEGylated gold nanoparticles","volume":"494","author":"He","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e28256_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109585","article-title":"Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3\/JAK2 signaling regulated by ROS","volume":"125","author":"Liang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e28256_bib43","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1021\/acsanm.8b00572","article-title":"Pluronic\/heparin nanoparticles for chemo-photodynamic combination cancer therapy through photoinduced caspase-3 activation","volume":"1","author":"Khaliq","year":"2018","journal-title":"ACS Appl. Nano Mater."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024042877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024042877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:05:21Z","timestamp":1784207121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024042877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024042877"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28256","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic nanocarriers loaded with temozolomide by cloaking brain-targeting peptides for targeting drug delivery system to promote anticancer effects in glioblastoma cells","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e28256"}}